Standard Biotools

Yahoo Finance • 2 months ago

Standard BioTools to Announce Fourth Quarter and Full Year 2025 Financial Results on February 24, 2026

BOSTON, Mass., Feb. 10, 2026 (GLOBE NEWSWIRE) -- Standard BioTools Inc. (NASDAQ: LAB) today announced that it will publish fourth quarter and full year 2025 financial results on Tuesday, February 24, 2026, after U.S. market close. About... Full story

Yahoo Finance • 3 months ago

Labrador Gold Announces Acquisition of Subscription Receipts of Northern Shield

TORONTO, Dec. 31, 2025 (GLOBE NEWSWIRE) -- Labrador Gold Corp. (TSX.V: LAB | OTCQB: NKOSF | FNR: 2N6) (“LabGold” or the “Company”) is pleased to announce that, further to its press release of December 8, 2025 (the “COB Press Release”), i... Full story

Yahoo Finance • 4 months ago

Labrador Gold Announces Annual General and Special Meeting of Shareholders in Connection With A Proposed Change of Business

Proposes Change of Business to a mining/investment issuer Adds renowned geologist Dr. Quinton Hennigh as Investment Advisor Mr. Kevin Ramsay, CPA, CA, will join the Board of Directors Annual General and Special Meeting to be held on Februa... Full story

Yahoo Finance • 4 months ago

Penny Stocks To Watch In December 2025

As November 2025 draws to a close, the U.S. stock market has seen a robust week, with major indexes logging their best performance since June, despite the Nasdaq's seven-month winning streak coming to an end. For investors seeking opportun... Full story

Yahoo Finance • 5 months ago

MODD, LAB, HOWL, COGT, LGVN, ABCL Lead Biotech After-Hours Rally - Nov 26

(RTTNews) - Several biotech and life sciences companies posted notable gains in after-hours trading on Wednesday, November 26, reflecting investor interest despite a relatively quiet news cycle. Modular Medical, Inc. (MODD) shares surged... Full story

Yahoo Finance • 5 months ago

After-Hours Gainers: MGNX, SLS, KRMD, HYPR, WVE Post Sharp Moves Following Q3 Updates

(RTTNews) - Several small-cap healthcare and biotech names posted notable price increases in after-hours trading on Wednesday, following earnings updates or ahead of scheduled financial disclosures. MacroGenics, Inc. (MGNX) rose 10.2% to... Full story

Yahoo Finance • 5 months ago

Labrador Gold Provides Update on Exploration at the Hopedale and Borden Lake Extension Gold Projects

TORONTO, Nov. 06, 2025 (GLOBE NEWSWIRE) -- Labrador Gold Corp. (TSX.V: LAB | OTCQB: NKOSF | FNR: 2N6) (“LabGold” or the “Company”) is pleased to provide an update on its 2025 exploration programs at the Hopedale, Labrador and Borden Lake... Full story

Yahoo Finance • 6 months ago

Standard BioTools to Announce Third Quarter Financial Results on November 4, 2025

SOUTH SAN FRANCISCO, Calif., Oct. 21, 2025 (GLOBE NEWSWIRE) -- Standard BioTools Inc. (NASDAQ: LAB) today announced that it will publish third quarter 2025 financial results on Tuesday, November 4, 2025, after U.S. market close. About S... Full story

Yahoo Finance • 8 months ago

Casdin funds buys Standard Biotools (LAB) shares worth $443,032

Casdin Partners Master Fund, L.P., along with other related entities, reported purchasing shares of Standard Biotools Inc. NASDAQ:LAB, totaling $443,032. The purchases, executed between August 13 and August 15, 2025, were made at prices ra... Full story

Yahoo Finance • 8 months ago

Labrador Gold Sets Date for Annual Meeting

TORONTO, Aug. 13, 2025 (GLOBE NEWSWIRE) -- Labrador Gold Corp. (TSX.V: LAB | OTCQB: NKOSF | FNR: 2N6) (“LabGold” or the “Company”) is pleased to announce that it will be holding its Annual General & Special Meeting of Shareholders on Tue... Full story

Yahoo Finance • 8 months ago

Standard BioTools Reports Second Quarter 2025 Financial Results

SOUTH SAN FRANCISCO, Calif., Aug. 11, 2025 (GLOBE NEWSWIRE) -- Standard BioTools Inc. (NASDAQ: LAB) (the “Company” or “Standard BioTools”) today announced financial results for the second quarter ended June 30, 2025. Standard BioTools wi... Full story

Yahoo Finance • 9 months ago

Drug Abuse Testing Market Forecast and Company Analysis Report 2025-2033 Featuring Danaher, LabCorp, Abbott, Quest Diagnostics, Thermo Fisher Scientific, F. Hoffmann-La Roche, Bio-Rad, Medtronic

Dublin, July 30, 2025 (GLOBE NEWSWIRE) -- The "Drug Abuse Testing Market Size and Share Analysis - Growth Trends and Forecast Report 2025-2033" report has been added to ResearchAndMarkets.com's offering. Drug Abuse Testing Market is... Full story

Yahoo Finance • 9 months ago

Standard BioTools Schedules Second Quarter Earnings Conference Call on August 11, 2025

SOUTH SAN FRANCISCO, Calif., July 21, 2025 (GLOBE NEWSWIRE) -- Standard BioTools Inc. (NASDAQ: LAB) today announced that it will report second quarter 2025 financial results on Monday, August 11, 2025, after market close. The company wil... Full story

Yahoo Finance • 10 months ago

Tesla and AMD Lead Market Cap Stock Movers on Monday

Monday’s market has seen notable fluctuations among various stocks, particularly within the mega-cap and large-cap categories. Tesla Motors (NASDAQ:TSLA) and Advanced Micro Devices (NASDAQ:AMD) are experiencing significant rallies, while... Full story

Yahoo Finance • 10 months ago

Standard BioTools jumps on sale of SomaLogic to Illumina

* Standard BioTools (NASDAQ:LAB [https://seekingalpha.com/symbol/LAB]) shares jumped as much as 19% premarket on Monday after the company announced the sale of its SomaLogic business to Illumina (NASDAQ:ILMN [https://seekingalpha.com/sym... Full story

Yahoo Finance • 10 months ago

Standard BioTools sells SomaLogic to Illumina for up to $425 million

SOUTH SAN FRANCISCO - Standard BioTools Inc. (NASDAQ:LAB) announced today the sale of its SomaLogic business to Illumina, Inc. (NASDAQ:ILMN), a $14.3 billion market cap genomics leader with annual revenue of $4.3 billion, for $350 million... Full story

Yahoo Finance • 10 months ago

Standard BioTools Enters Next Phase of Transformation with Strategic Sale of SomaLogic to Illumina

Up To $425 Million In Total Proceeds Inclusive of Near-term Milestone Payments; $350 Million In Upfront Cash Retains Strategic Upside with Illumina Protein Prep Royalty Stream and Rights to Single SOMAmer Reagent Business Simplifies O... Full story

Yahoo Finance • 11 months ago

Standard BioTools to Host Inaugural “Proteomics Roundtable” Webcast Series

SOUTH SAN FRANCISCO, Calif., May 30, 2025 (GLOBE NEWSWIRE) -- Standard BioTools Inc. (NASDAQ: LAB) today announced the launch of its inaugural Proteomics Roundtable Series – a program of virtual events designed to spark conversation abou... Full story

Yahoo Finance • 11 months ago

Standard BioTools Reports First Quarter 2025 Financial Results

SOUTH SAN FRANCISCO, Calif., May 06, 2025 (GLOBE NEWSWIRE) -- Standard BioTools Inc. (NASDAQ: LAB) (the “Company” or “Standard BioTools”) today announced financial results for the first quarter ended March 31, 2025. Recent Highlights:... Full story

Yahoo Finance • 12 months ago

Standard BioTools Schedules First Quarter Earnings Conference Call on May 6, 2025

SOUTH SAN FRANCISCO, Calif., April 22, 2025 (GLOBE NEWSWIRE) -- Standard BioTools Inc. (NASDAQ: LAB) today announced that it will report first quarter 2025 financial results on Tuesday, May 6, 2025, after market close. The company will h... Full story